secwatch.observer — SEC 8-K summary
======================================

Issuer:     INVO Fertility, Inc. (IVF)
CIK:        0001417926
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0001493152-24-012342
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INVO Bioscience enters $850K equity purchase agreement with Triton Funds, issues warrants at $2.00/share
--------------------------------------------------------------------------------

- Up to 1,000,000 shares at $0.85/share sold to Triton, aggregate proceeds capped at $850,000.
- Private placement warrants for 1,000,000 shares at $2.00/share, immediately exercisable, expire in 5 years.
- Purchase agreement expires Dec 31, 2024; Triton obligated to buy on Company's request but no shorting allowed.
- Until shareholder approval, shares issued limited to 523,344 (19.9% of outstanding common stock) under Nasdaq rules.
- Proceeds used for general corporate purposes; warrants unregistered and no trading market expected.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417926/000149315224012342/0001493152-24-012342-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417926/000149315224012342/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-012342

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer